%0 Journal Article %A Lixiang Lou %A Hui Zhang %A Baoming Tang %A Ming Li %A Zeqing Li %A Haifang Cao %A Jian Li %A Yuliang Chong %A Zhaowei Li %T Clinical characteristics of COVID-19 in children and adolescents: a systematic review and meta-analysis %D 2021 %R 10.1101/2021.03.12.21253472 %J medRxiv %P 2021.03.12.21253472 %X Background Although the number of COVID-19 (coronavirus disease 2019) cases continues to increase globally, there are few studies on the clinical characteristics of children and adolescents with COVID-19.Objective To conduct a comprehensive systematic evaluation and meta-analysis of the clinical characteristics of COVID-19 in children and adolescents to better guide the response to the current epidemic.Methods We searched PubMed, Embase, the Cochrane Library, Web of Science, CNKI (Chinese database), Clinical Trials.gov and chictr.org.cn (China). The methodological quality of the included literature was evaluated using the Quality Assessment Tool for Case Series Studies. Meta-analysis was performed using STATA 14.0. Heterogeneity was assessed by the Q statistic and quantified using I2. We used fixed-effects or random-effects models to pool clinical data in the meta-analysis. Publication bias was evaluated by the Begg’s test.Results We analyzed 49 studies involving 1627 patients. In the pooled data, the most common clinical symptoms were fever (56% [0.50−0.61]) and cough (45% [0.39−0.51]). The most common laboratory abnormalities were elevated procalcitonin (40% [0.23−0.57]), elevated lactate dehydrogenase (31% [0.19−0.43]), increased lymphocyte count (28% [0.17−0.42]), increased creatine kinase (28% [0.18− 0.40]), and elevated C-reactive protein (26% [0.17−0.36]). The most common abnormalities determined by computed tomography were lower-lobe involvement (56% [0.42-0.70]), ground-glass opacities (33% [0.25−0.42]), bilateral pneumonia (32% [0.24-0.40]), patchy shadowing (31% [0.18-0.45]), and upper lobe involvement (30% [0.20-0.41]).Conclusion Disease severity among children and adolescents with COVID-19 was milder than that among adult patients, with a greater proportion of mild and asymptomatic cases, and thus, the diagnosis of COVID-19 and control of the infection source are more challenging.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe authors state that this work has not received financial support.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Not applicable. This article does not contain any studies with human participants performed by any of the authors.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data generated or analyzed during this study are included in this article. %U https://www.medrxiv.org/content/medrxiv/early/2021/03/13/2021.03.12.21253472.full.pdf